Abdi İbrahim has announced a technology transfer agreement with mAbxience.
Abdi Ibrahim Pharmaceuticals, the leader in the Turkish pharmaceutical industry for 21 years, continues its unwavering commitment to investing in biotechnology. Abdi İbrahim has announced a technology transfer agreement with the Spanish biosimilar developer, which is among the world’s leading…